Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Arcadia Biosciences, Inc. shareholders approved To approve an amendment to the Company’s amended and restated certificate of incorporation to effect, at the discretion of the Company’s Board of Directors (“Board”) but prior to June 30, 2023, a reverse stock split of all of the outstanding shares of our Common Stock at a ratio in the range of 1-fo at the 2023-02-15 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-02-15
Exact text from the filing
1. To approve an amendment to the Company’s amended and restated certificate of incorporation to effect, at the discretion of the Company’s Board of Directors (“Board”) but prior to June 30, 2023, a reverse stock split of all of the outstanding shares of our Common Stock at a ratio in the range of 1-for-10 to 1-for-40, with such ratio to be determined by the Board in its discretion (“Reverse Stock Split Proposal”). FOR AGAINST ABSTAIN Broker Non-Votes 9,730,160,440 1,678,239,563 229,293,064 --
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Arcadia Biosciences, Inc. shareholders approved To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal. at the 2023-02-15 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-02-15
Exact text from the filing
2. To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal. FOR AGAINST ABSTAIN Broker Non-Votes 9,995,797,812 1,260,616,357 381,278,898 --
View on SEC.gov